Cart
sales@molnova.com
PLH2058
CAS No. 2525206-41-9
PLH2058( —— )
Catalog No. M36853 CAS No. 2525206-41-9
PLH2058 is a compound that can be used to regulate, limit or inhibit AVIL (advillin) expression. It can be used in the treatment of cancer.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 148 | In Stock |
|
| 10MG | 217 | In Stock |
|
| 25MG | 364 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePLH2058
-
NoteResearch use only, not for human use.
-
Brief DescriptionPLH2058 is a compound that can be used to regulate, limit or inhibit AVIL (advillin) expression. It can be used in the treatment of cancer.
-
DescriptionPLH2058 is a compound that can be used to regulate, limit or inhibit AVIL (advillin) expression. It can be used in the treatment of cancer.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2525206-41-9
-
Formula Weight360.49
-
Molecular FormulaC24H28N2O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(CCC1=CC=CC=C1)C2(CO)CN(CCC2)C=3C4=C(C=CN3)C=CC=C4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Codrituzumab
Codrituzumab (GC3) is a humanized antibody against the glypican-3 hepatocellular carcinoma protein that can be used in combination with sorafenib to study incurable advanced hepatocellular carcinoma (HCC).
-
Hesperetin-7-methyl ...
Hesperetin-7-methyl ether
-
Saposin C22
Saposin C22
